<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863549</url>
  </required_header>
  <id_info>
    <org_study_id>MucS001-17</org_study_id>
    <nct_id>NCT02863549</nct_id>
  </id_info>
  <brief_title>MitraClip for Severe TR</brief_title>
  <acronym>TVrepair</acronym>
  <official_title>Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum der Universitaet Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum der Universitaet Muenchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the procedural feasibility and 30-day results of
      transcatheter tricuspid valve repair using the MitraClip® system (Abbott Vascular) in
      selected, highly symptomatic patients with severe tricuspid regurgitation (TR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of this prospective analysis were to determine the feasibility in
      terms of success rate and short-term clinical follow-up at 30 days. In this context
      procedural success was defined as reduction of at least one TR grade. At 30-days after the
      procedure, a clinical follow up was performed in the heart failure outpatient clinic of our
      department including transthoracic echocardiography for the evaluation of TR grades.
      Furthermore, the investigators determined NYHA functional class and the incidence of major
      adverse cardiac and cerebrovascular events (MACCE).

      Secondary objectives were the assessment of right ventricular function, the 6-minute walk
      distance, NT-proBNP as well as quality of life as assessed by the Minnesota Living with Heart
      Failure Questionnaire (MLHFQ) score at 30-days follow up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TR grade, Echo (grade 0-4)</measure>
    <time_frame>1-12 months</time_frame>
    <description>grade 0-4: 0: no tricuspid regurgitation, 4: massive TR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACCE</measure>
    <time_frame>1-12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>NYHA status</measure>
    <time_frame>1-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute walk distance</measure>
    <time_frame>1-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NT-proBNP</measure>
    <time_frame>1-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MLHFQ</measure>
    <time_frame>1-12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tricuspid Regurgitation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MitraClip in tricuspid valve</intervention_name>
    <description>MitraClip in tricuspid valve</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  right-sided heart failure due to moderate-to-severe tricuspid regurgitation

          -  patients deemed inoperable by the heart Team

        Exclusion Criteria:

          -  poor Echo-image quality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Braun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Universität München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Braun, MD</last_name>
    <phone>+49 89 4400</phone>
    <phone_ext>73052</phone_ext>
    <email>Daniel.Braun@med.uni-muenchen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum Großhadern University Hospital</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Braun, MD</last_name>
      <phone>+49 89 4400</phone>
      <phone_ext>73052</phone_ext>
      <email>Daniel.Braun@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>August 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 6, 2016</last_update_submitted>
  <last_update_submitted_qc>August 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum der Universitaet Muenchen</investigator_affiliation>
    <investigator_full_name>Daniel Braun, MD</investigator_full_name>
    <investigator_title>MD, Attending Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

